查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2079632

血清乳酸檢測市場趨勢、競爭格局及市場預測－2033年

Serum Lactate Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 199 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著醫療專業人員在重症監護、急診醫學和敗血症管理中日益重視快速診斷檢測，全球血清乳酸檢測市場預計將穩定成長。該市場預計將從2026年的2.1億美元成長到2033年的3.0346億美元，預測期內複合年成長率（CAGR）為5.4%。敗血症發病率的上升、重症監護基礎設施的擴建以及即時診斷（POC）技術的日益普及預計將推動全球市場的持續成長。

介紹

血清乳酸檢測已成為評估組織氧合和檢測危及生命的疾病（如敗血症、敗血性休克、創傷、心臟急症和呼吸衰竭）的重要診斷工具。醫護人員利用血清乳酸濃度及時做出臨床決策、評估疾病嚴重程度、監測治療效果並提高病患存活率。

診斷技術的不斷進步，攜帶式分析儀、自動化檢測系統和即時檢測設備的出現，使得血清乳酸檢測更加快速準確，並在醫院、急診科、加護病房和門診等場所得到廣泛應用。隨著早期診斷和循證治療方案在醫療保健系統中日益重要，對先進血清乳酸檢測解決方案的需求預計將保持強勁。

市場趨勢

由於急診醫學和重症監護領域對快速診斷檢測的日益普及，血清乳酸檢測市場正經歷穩定成長。醫院正在部署先進的分析設備和即時檢測平台，以縮短檢測結果的報告時間，使臨床醫生能夠及時採取乾預措施，改善患者預後。

隨著人們對乳酸治療在急診醫學和重症監護領域應用的認知不斷提高，醫療機構正將血清乳酸檢測納入常規臨床診療流程。同時，攜帶式分析儀和連續監測技術的進步，使得檢測範圍從中心檢查室擴展到門診、居家醫療、運動醫學和遠端醫療等領域。

以自動化、數位連接、無線數據傳輸和提高分析準確性為重點的技術創新，不斷提高檢查室效率，並促進其在臨床環境中的更廣泛應用。

市場促進因素

市場成長的主要促進因素之一是全球範圍內敗血症和其他嚴重負擔的日益加重，這些疾病需要快速診斷和持續的病患監測。早期血清乳酸評估在識別高風險患者、制定治療策略和改善臨床結果方面發揮著至關重要的作用，使其成為急診醫學和重症監護中不可或缺的一部分。

對醫療基礎設施、加護病房和先進診斷檢查室的投資增加，也推動了對尖端血清乳酸檢測解決方案的需求成長。醫療機構在擴展檢查室能力的同時，也正在實施整合診斷平台，以簡化工作流程並改善臨床決策。

此外，在即時檢測需求不斷成長的推動下，製造商正在開發緊湊攜帶式的分析儀，以便在急診室、救護車、社區醫療機構和災害救援現場快速可靠地測量乳酸水平。政府旨在加強醫療服務和改善疾病早期檢測的措施也進一步促進了市場成長。

商業機會

血清乳酸檢測市場蘊藏著龐大的商機，這得益於連續監測技術、穿戴式生物感測器和人工智慧診斷平台的發展。隨著醫療保健系統日益擁抱數位化健康生態系統，製造商們正積極尋求將乳酸檢測與電子健康記錄(EHR)、遠端患者監護平台和臨床決策支援系統整合的機會。

隨著各國政府持續投資於醫療現代化和擴大先進診斷服務的覆蓋範圍，新興經濟體也展現出巨大的成長潛力。隨著「居家醫院」計畫、遠端醫療和遠端患者監護的日益普及，對攜帶式、易用的血清乳酸檢測設備的需求預計將會成長。

專注於提供價格實惠、高精度且具備數位連接功能的診斷解決方案的製造商，預計將在已開發和開發中國家中醫療保健市場中鞏固其市場地位。

區域分析

北美地區憑藉先進的醫療基礎設施、敗血症管理方案的廣泛應用以及即時診斷技術的高普及率，繼續在全球血清乳酸檢測市場佔據主導地位。完善的保險報銷體系和對重症監護診斷的持續投入，進一步鞏固了該地區的市場領導地位。

由於歐洲擁有完善的醫療保健體系，臨床上對早期發現敗血症的重要性認知不斷提高，並且持續投資於檢查室現代化和診斷技術創新，因此歐洲仍然是一個重要的市場。

在東亞，受醫療保健支出增加、醫院基礎設施改善以及主要醫療機構擴大採用先進診斷技術的推動，預計將出現強勁成長。

由於醫療基礎設施的擴張、政府對緊急醫療服務投入的增加以及獲得最先進診斷設備的便利，南亞和大洋洲正在成為有發展前景的區域市場。

在拉丁美洲、中東和非洲，隨著醫療保健服務的改善以及醫院不斷投資於先進的診斷技術和重症監護設施，市場預計將穩步成長。

競爭格局

全球血清乳酸檢測市場集中度適中，領導企業透過技術創新、診斷準確性、數位化整合和全面的服務方案競爭。各企業持續加大研發投入，以提升分析儀器的效能和便攜性，並實現與醫院資訊系統和互聯醫療平台的無縫整合。

策略聯盟、法規核准、新產品發布、收購以及向新興醫療保健市場擴張是業內公司為增強競爭力、擴大全球企業發展而持續採用的關鍵策略。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監管分析
  • 價格趨勢分析
    • 目前價格及未來預測（2025-2033年）
    • 影響價格的因素

第3章：2020-2033年全球血清乳酸檢測市場展望

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按地區和數量（噸）
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章：2020-2033年北美血清乳酸檢測市場展望

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按國家和數量（噸）
    • 美國
    • 加拿大
  • BPS分析與市場吸引力分析

第5章：2020-2033年歐洲血清乳酸檢測市場展望

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按國家和數量（噸）
    • 德國
    • 義大利
    • 法國
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • BPS分析與市場吸引力分析

第6章：亞太地區血清乳酸檢測市場展望（2020-2033年）

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按國家和數量（噸）
    • 中國
    • 日本
    • 韓國
    • 印度
    • 東南亞
    • 其他南亞國家
  • BPS分析與市場吸引力分析

第7章：2020-2033年拉丁美洲血清乳酸檢測市場展望

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按國家和數量（噸）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • BPS分析與市場吸引力分析

第8章：2020-2033年中東和非洲血清乳酸檢測市場展望

  • 按產品類型和數量（噸）
    • 桌面分析儀
    • 攜帶式測量儀器
    • 攜帶式POCT分析儀
    • 測試條和試劑盒
    • 用於連續監測的感測器
    • 其他
  • 按應用和數量（噸）
    • 敗血症監測
    • 運動表現
    • 創傷與急診醫學
    • 術後護理
    • 其他
  • 按最終用戶和數量（噸）
    • 醫院
    • 診斷檢查室
  • 按國家和數量（噸）
    • GCC
    • 南非
    • 埃及
    • 奈及利亞
    • 其他中東國家
  • BPS分析與市場吸引力分析

第9章 競爭情勢

  • 公司特定和細分市場特定的熱圖
  • 企業市佔率分析，2025 年
  • 競爭對手儀錶板
  • 公司簡介
    • Roche Diagnostics
    • Abbott Laboratories
    • Siemens Healthineers
    • Radiometer
    • Nova Biomedical
    • EKF Diagnostics
    • Werfen Beckman Coulter
    • Mindray Medical International
    • bioMerieux
    • Sysmex Corporation
    • Biolinq
    • Hoffmann-La Roche
    • Epicore Biosystems
    • i-STAT

第10章附錄

簡介目錄

The global Serum Lactate Testing Market is expected to witness steady growth as healthcare providers increasingly emphasize rapid diagnostic testing for critical care, emergency medicine, and sepsis management. According to the latest study by Fairfield Market Research, the market is projected to grow from US$ 210 Million in 2026 to US$ 303.46 Million by 2033, registering a CAGR of 5.4% during the forecast period. Rising incidences of sepsis, expanding critical care infrastructure, and increasing adoption of point-of-care (POC) diagnostic technologies are expected to support sustained market expansion worldwide.

Introduction

Serum lactate testing has become an indispensable diagnostic tool for evaluating tissue oxygenation and detecting life-threatening conditions such as sepsis, septic shock, trauma, cardiac emergencies, and respiratory failure. Healthcare professionals rely on serum lactate measurements to make timely clinical decisions, assess disease severity, monitor treatment response, and improve patient survival outcomes.

Continuous advancements in diagnostic technologies, portable analyzers, automated laboratory systems, and point-of-care testing devices are making serum lactate testing faster, more accurate, and widely accessible across hospitals, emergency departments, intensive care units, and outpatient settings. As healthcare systems increasingly prioritize early diagnosis and evidence-based treatment protocols, demand for advanced serum lactate testing solutions is expected to remain strong.

Market Insights

The Serum Lactate Testing Market is experiencing consistent growth due to the increasing adoption of rapid diagnostic testing across critical care and emergency medicine environments. Hospitals are integrating advanced analyzers and point-of-care platforms that provide faster turnaround times, enabling clinicians to initiate timely interventions and improve patient outcomes.

Growing awareness of lactate-guided therapy in emergency and intensive care medicine has encouraged healthcare institutions to standardize serum lactate testing as part of routine clinical protocols. At the same time, portable analyzers and continuous monitoring technologies are expanding testing applications beyond centralized laboratories into ambulatory care, home healthcare, sports medicine, and remote healthcare environments.

Technological innovations focused on automation, digital connectivity, wireless data transmission, and enhanced analytical precision continue to improve laboratory efficiency while supporting broader clinical adoption.

Market Drivers

One of the primary drivers of market growth is the increasing global burden of sepsis and other critical illnesses requiring rapid diagnosis and continuous patient monitoring. Early serum lactate assessment plays a crucial role in identifying high-risk patients, guiding therapeutic decisions, and improving clinical outcomes, making it an essential component of emergency and intensive care.

Growing investments in healthcare infrastructure, intensive care units, and advanced diagnostic laboratories are also contributing to increased demand for modern serum lactate testing solutions. Healthcare providers are expanding laboratory capabilities while adopting integrated diagnostic platforms that improve workflow efficiency and clinical decision-making.

Additionally, rising preference for point-of-care testing is encouraging manufacturers to develop compact, portable analyzers capable of delivering rapid and reliable lactate measurements in emergency departments, ambulances, rural healthcare facilities, and disaster response settings. Government initiatives aimed at strengthening emergency healthcare services and improving early disease detection further support market growth.

Business Opportunity

The Serum Lactate Testing Market presents significant opportunities through the development of continuous monitoring technologies, wearable biosensors, and AI-powered diagnostic platforms. As healthcare systems increasingly embrace digital health ecosystems, manufacturers have opportunities to integrate lactate testing with electronic health records (EHRs), remote patient monitoring platforms, and clinical decision support systems.

Emerging economies also offer substantial growth potential as governments continue investing in healthcare modernization and expanding access to advanced diagnostic services. Increasing adoption of hospital-at-home programs, telemedicine, and remote patient monitoring is expected to create new demand for portable, user-friendly serum lactate testing devices.

Manufacturers focusing on affordable, highly accurate, and digitally connected diagnostic solutions are expected to strengthen their market positions across both developed and developing healthcare markets.

Regional Analysis

North America continues to dominate the global Serum Lactate Testing Market, supported by advanced healthcare infrastructure, widespread implementation of sepsis management protocols, and high adoption of point-of-care diagnostic technologies. Strong reimbursement systems and ongoing investments in critical care diagnostics further reinforce regional market leadership.

Europe remains a significant market due to its well-established healthcare systems, increasing clinical awareness of early sepsis detection, and continuous investments in laboratory modernization and diagnostic innovation.

East Asia is expected to experience robust growth, driven by rising healthcare expenditure, improving hospital infrastructure, and increasing adoption of advanced diagnostic technologies across major healthcare facilities.

South Asia & Oceania is emerging as a promising regional market owing to expanding healthcare infrastructure, growing government investments in emergency medical services, and increasing access to modern diagnostic equipment.

Latin America and the Middle East & Africa are anticipated to witness steady market growth as healthcare accessibility improves and hospitals continue investing in advanced diagnostic technologies and critical care facilities.

Competitive Landscape

The global Serum Lactate Testing Market is moderately consolidated, with leading manufacturers competing through technological innovation, diagnostic accuracy, digital integration, and comprehensive service offerings. Companies continue investing in research and development to enhance analyzer performance, improve portability, and enable seamless integration with hospital information systems and connected healthcare platforms.

Strategic collaborations, regulatory approvals, product launches, acquisitions, and expansion into emerging healthcare markets remain key strategies adopted by industry participants to strengthen their competitive positions and expand their global footprint.

Key Players

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Radiometer
  • Nova Biomedical
  • EKF Diagnostics
  • Werfen
  • Beckman Coulter
  • Mindray Medical International
  • bioMerieux
  • Sysmex Corporation
  • Biolinq
  • Hoffmann-La Roche
  • Epicore Biosystems
  • i-STAT

Future Outlook

The future of the Serum Lactate Testing Market remains promising as healthcare providers increasingly focus on early disease detection, rapid clinical decision-making, and personalized patient care. Continuous advancements in biosensor technologies, wearable monitoring devices, AI-assisted diagnostics, and point-of-care testing platforms are expected to transform the competitive landscape over the coming years.

Growing investments in digital healthcare infrastructure, expanding emergency care services, and increasing awareness of timely sepsis diagnosis and management will continue to drive sustained demand for serum lactate testing solutions throughout the forecast period.

Market Segmentation

By Product Type

  • Benchtop Analyzers
  • Handheld Meters
  • Portable POCT Analyzers
  • Test Strips & Cartridges
  • Continuous Monitoring Sensors
  • Others

By Application

  • Sepsis Monitoring
  • Sports Performance
  • Trauma & Emergency Care
  • Post-surgical Care
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Point-of-care Clinics
  • Ambulatory Surgical Centers
  • Sports Institutes
  • Home Care Settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Serum Lactate Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Serum Lactate Testing Market Outlook, 2020-2033

  • 3.1. Global Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 3.1.1. Benchtop analyzers
    • 3.1.2. Handheld meters
    • 3.1.3. Portable POCT analyzers
    • 3.1.4. Test strips & cartridge
    • 3.1.5. Continuous monitoring sensors
    • 3.1.6. Others
  • 3.2. Global Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 3.2.1. Sepsis monitoring
    • 3.2.2. Sports performance
    • 3.2.3. Trauma & emergency care
    • 3.2.4. Post-surgical care
    • 3.2.5. Others
  • 3.3. Global Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Diagnostic laboratories
  • 3.4. Global Serum Lactate Testing Market Outlook, by Region, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Serum Lactate Testing Market Outlook, 2020-2033

  • 4.1. North America Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 4.1.1. Benchtop analyzers
    • 4.1.2. Handheld meters
    • 4.1.3. Portable POCT analyzers
    • 4.1.4. Test strips & cartridge
    • 4.1.5. Continuous monitoring sensors
    • 4.1.6. Others
  • 4.2. North America Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 4.2.1. Sepsis monitoring
    • 4.2.2. Sports performance
    • 4.2.3. Trauma & emergency care
    • 4.2.4. Post-surgical care
    • 4.2.5. Others
  • 4.3. North America Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostic laboratories
  • 4.4. North America Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 4.4.1. U.S. Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 4.4.2. U.S. Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 4.4.3. U.S. Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 4.4.5. Canada Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 4.4.6. Canada Serum Lactate Testing Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Serum Lactate Testing Market Outlook, 2020-2033

  • 5.1. Europe Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 5.1.1. Benchtop analyzers
    • 5.1.2. Handheld meters
    • 5.1.3. Portable POCT analyzers
    • 5.1.4. Test strips & cartridge
    • 5.1.5. Continuous monitoring sensors
    • 5.1.6. Others
  • 5.2. Europe Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 5.2.1. Sepsis monitoring
    • 5.2.2. Sports performance
    • 5.2.3. Trauma & emergency care
    • 5.2.4. Post-surgical care
    • 5.2.5. Others
  • 5.3. Europe Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Diagnostic laboratories
  • 5.4. Europe Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 5.4.1. Germany Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.2. Germany Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.3. Germany Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.5. Italy Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.6. Italy Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.7. France Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.8. France Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.9. France Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.11. U.K. Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.12. U.K. Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.14. Spain Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.15. Spain Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.17. Russia Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.18. Russia Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 5.4.20. Rest of Europe Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 5.4.21. Rest of Europe Serum Lactate Testing Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Serum Lactate Testing Market Outlook, 2020-2033

  • 6.1. Asia Pacific Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 6.1.1. Benchtop analyzers
    • 6.1.2. Handheld meters
    • 6.1.3. Portable POCT analyzers
    • 6.1.4. Test strips & cartridge
    • 6.1.5. Continuous monitoring sensors
    • 6.1.6. Others
  • 6.2. Asia Pacific Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 6.2.1. Sepsis monitoring
    • 6.2.2. Sports performance
    • 6.2.3. Trauma & emergency care
    • 6.2.4. Post-surgical care
    • 6.2.5. Others
  • 6.3. Asia Pacific Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic laboratories
  • 6.4. Asia Pacific Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 6.4.1. China Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.2. China Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.3. China Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.5. Japan Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.6. Japan Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.8. South Korea Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.9. South Korea Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 6.4.10. India Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.11. India Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.12. India Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.14. Southeast Asia Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.15. Southeast Asia Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 6.4.17. Rest of SAO Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 6.4.18. Rest of SAO Serum Lactate Testing Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Serum Lactate Testing Market Outlook, 2020-2033

  • 7.1. Latin America Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 7.1.1. Benchtop analyzers
    • 7.1.2. Handheld meters
    • 7.1.3. Portable POCT analyzers
    • 7.1.4. Test strips & cartridge
    • 7.1.5. Continuous monitoring sensors
    • 7.1.6. Others
  • 7.2. Latin America Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 7.2.1. Sepsis monitoring
    • 7.2.2. Sports performance
    • 7.2.3. Trauma & emergency care
    • 7.2.4. Post-surgical care
    • 7.2.5. Others
  • 7.3. Latin America Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic laboratories
  • 7.4. Latin America Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 7.4.1. Brazil Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 7.4.2. Brazil Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 7.4.3. Brazil Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 7.4.5. Mexico Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 7.4.6. Mexico Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 7.4.8. Argentina Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 7.4.9. Argentina Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 7.4.11. Rest of LATAM Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 7.4.12. Rest of LATAM Serum Lactate Testing Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Serum Lactate Testing Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Serum Lactate Testing Market Outlook, by Product Type, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 8.1.1. Benchtop analyzers
    • 8.1.2. Handheld meters
    • 8.1.3. Portable POCT analyzers
    • 8.1.4. Test strips & cartridge
    • 8.1.5. Continuous monitoring sensors
    • 8.1.6. Others
  • 8.2. Middle East & Africa Serum Lactate Testing Market Outlook, by Application, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 8.2.1. Sepsis monitoring
    • 8.2.2. Sports performance
    • 8.2.3. Trauma & emergency care
    • 8.2.4. Post-surgical care
    • 8.2.5. Others
  • 8.3. Middle East & Africa Serum Lactate Testing Market Outlook, by End User, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic laboratories
  • 8.4. Middle East & Africa Serum Lactate Testing Market Outlook, by Country, Value (US$ Mn) & Volume (Tons), 2020-2033
    • 8.4.1. GCC Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 8.4.2. GCC Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 8.4.3. GCC Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 8.4.5. South Africa Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 8.4.6. South Africa Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 8.4.8. Egypt Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 8.4.9. Egypt Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 8.4.11. Nigeria Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 8.4.12. Nigeria Serum Lactate Testing Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Serum Lactate Testing Market Outlook, by Product Type, 2020-2033
    • 8.4.14. Rest of Middle East Serum Lactate Testing Market Outlook, by Application, 2020-2033
    • 8.4.15. Rest of Middle East Serum Lactate Testing Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Roche Diagnostics
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Abbott Laboratories
    • 9.4.3. Siemens Healthineers
    • 9.4.4. Radiometer
    • 9.4.5. Nova Biomedical
    • 9.4.6. EKF Diagnostics
    • 9.4.7. Werfen Beckman Coulter
    • 9.4.8. Mindray Medical International
    • 9.4.9. bioMerieux
    • 9.4.10. Sysmex Corporation
    • 9.4.11. Biolinq
    • 9.4.12. Hoffmann-La Roche
    • 9.4.13. Epicore Biosystems
    • 9.4.14. i-STAT

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations